Jan 15, 2016 Issue
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Recommendation Statement [U.S. Preventive Services Task Force]

The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity.

Dec 1, 2015 Issue
Adding Sitagliptin Does Not Reduce or Increase the Risk of Cardiovascular Outcomes [POEMs]

The glass half full is that sitagliptin does not increase the risk of cardiovascular events in patients with type 2 diabetes. The glass half empty is that it does not reduce the risk, either. And that is the important message: In patients with a mean glycated hemoglobin level of 7.2%, adding sitagli...

Jul 1, 2015 Issue
Type 2 Diabetes: Updated Evidence Requires Updated Decision Making [Editorials]

Clinicians need to consider the best available research findings, their own experience, and their patients' needs and values.

Jul 1, 2015 Issue
Management of Blood Glucose with Noninsulin Therapies in Type 2 Diabetes [Article]

Review the key components of diabetes treatment, including nutrition, exercise, and pharmacologic therapies. Metformin is the first-line choice of hypoglycemic agents to reduce mortality and complications. Learn which A1C goals are most appropriate for patients.

Jun 15, 2015 Issue
Dapagliflozin (Farxiga) for Type 2 Diabetes Mellitus [STEPS]

Dapagliflozin will lower A1C levels by an average of 0.7 percentage points when used alone or by an average of 0.5 percentage points when added to metformin therapy. Its effect on diabetes-associated morbidity and mortality has not been studied, and although it is well tolerated, there is an associa...

Jun 1, 2015 Issue
Individualizing Target Goals and Treatment in Patients with Type 2 Diabetes [POEMs]

This statement from American and European diabetes societies suggests that tighter control of hyperglycemia be attempted only in patients with a recent diagnosis and a low risk of hypoglycemia; who have a long life expectancy with few or no comorbidities, including cardiovascular disease; and who ar...

Jun 1, 2015 Issue
Tight Glycemic Control for Type 2 Diabetes Mellitus (Over Five Years) [Medicine by the Numbers]

Studies show that none were helped and 1 in 6 patients were harmed. See why.

Feb 15, 2015 Issue
Metformin Associated with Less Need for a Second Medicine [POEMs]

n this retrospective analysis, which benefits from large numbers of patients but suffers from possible biases, patients who initially took an oral hypoglycemic other than metformin (Glucophage) were significantly more likely to require a second oral agent.

Oct 15, 2014 Issue
Bariatric Surgery Plus Intensive Medical Therapy Is Better Than Medical Therapy Alone for Diabetes [POEMs]

Bariatric surgery in conjunction with intensive medical therapy results in significantly enhanced glycemic control at three years compared with medical therapy alone, as well as better weight control, less use of glucose-lowering medications, and improved quality of life.

Sep 15, 2014 Issue
Rosiglitazone, Medical Reversal, and Back to Basics for Diabetes [Editorials]

For too long, the debate in diabetes has centered on the question: Is this medication harmful? It's time to revisit the more fundamental question: Is this treatment beneficial?

Pages: Previous 1 2 3 4 5 6 7 8 9 10 ... 15 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now